Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-24 @ 11:36 PM
NCT ID:
NCT06887556
Eligibility Criteria:
Inclusion Criteria:
* Healthy males and females aged between ages 5-80 years, who are able and willing to provide informed consent and will comply with the study requirements.
* Group 1 (suspected exposure cohort) only
* Live within or adjacent to an epidemiologically identified region of Mpox transmission
* Close contacts of those with microbiologically confirmed Mpox
* Group 2 (post-exposure/vaccinated cohort) only
* Previous clinically or microbiologically confirmed Mpox or confirmed previous vaccination with a smallpox/MVA vaccine
* Fully recovered from Mpox infection
* Group 3 (control cohort) only:
* Asymptomatic with no known exposure to Mpox
Exclusion Criteria:
* Unwilling or unable to provide informed consent to take part
* Unwilling or unable to comply with study procedures
* History of any suspected or confirmed disorder of the immune system that, in the opinion of the investigators, might impair the results of the study
* Have a bleeding disorder deemed significant by a member of the study team
* Pregnant or breast-feeding females
* Group 1 (suspected exposure cohort) only
* Known history of Mpox infection
* Current symptoms consistent with Mpox
* Known exposure to Mpox in the last month
* Group 2 (post-exposure/vaccinated cohort) only
* Participants with any ongoing symptoms of Mpox, indicating incomplete recovery.
* Group 3 (control cohort only)
* Symptoms of Mpox
* Known exposure to Mpox in the last month
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
80 Years
Study:
NCT06887556
Study Brief:
Protocol Section:
NCT06887556